Member access

4-Traders Homepage  >  Shares  >  Euronext Alternext  >  NEOVACS    ALNEV   FR0004032746

NEOVACS (ALNEV)

361
 SummaryQuotesChart AnalysisNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Euronext Alternext
12/15/2014 12/16/2014 12/17/2014 12/18/2014 12/19/2014 Date
3.13(c) 1.35(c) 1.4(c) 1.37(c) 1.34(c) Last
502 911 7 809 548 5 407 120 2 302 199 818 550 Volume
-6.29% -56.87% +3.70% -2.14% -2.19% Change
More quotes
Company
Neovacs SA is a biotechnology company.It focuses on an active immunotherapy technology platform with applications in the treatment of autoimmune and inflammatory diseases and cancer.It focuses on development on two Kinoids: Tumor Necrosis Factor-Kinoid and Interferon-Kinoid.The Tumor Necrosis... 
More about the company
Surperformance© ratings of NEOVACS
Trading Rating : Investor Rating :
More Ratings
Chart NEOVACS
Duration : Period :
NEOVACS Technical Analysis Chart | ALNEV | FR0004032746 | 4-Traders
Full-screen chart
Financials (€)
Sales 2014 0,03 M
EBIT 2014 -7,94 M
Net income 2014 -6,86 M
Debt 2014 3,05 M
Yield 2014 -
Sales 2015 10,0 M
EBIT 2015 -3,40 M
Net income 2015 -6,70 M
Debt 2015 8,28 M
Yield 2015 -
PER 2014 -
PER 2015 0,38
EV / Sales 2014 982x
EV / Sales 2015 3,47x
Capitalization 26,4 M
More Financials
Latest news on NEOVACS
4d ago NEOVACS : Announces top line phase iib clinical trial results of tnf-kinoid in r..
4d ago NEOVACS : ANNOUNCES TOP LINE PHASE IIB CLINICAL TRIAL RESULTS OF TNF-KINOID IN R..
11/25 NEOVACS : granted 1 million euro in Research Tax Credit
11/24 NEOVACS : Granted 1 million euro in research tax credit
11/24 NEOVACS NEOVACS GRANTED 1 MILLION EU : Neovacs S.A.: NEOVACS GRANTED 1 MILLION E..
11/21 NEOVACS : secures a new equity line financing with Kepler Cheuvreux
11/21 NEOVACS : Secures a new equity line financing with kepler cheuvreux
11/21 NEOVACS : SECURES A NEW EQUITY LINE FINANCING WITH KEPLER CHEUVREUX (DGAP News)
More news
Sector news
1d ago ISIS PHARMACEUTICALS : IWM, HEZU: Big ETF Inflows
1d ago PUMA BIOTECHNOLOGY : SHAREHOLDER ALERT: Investigation on Behalf of Investors of ..
1d ago ALNYLAM PHARMACEUTICALS : Announces Planned Departure of Chief Business Officer,..
More sector news


Comments 
Advertisement
Technical analysis trends
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF